Press Releases

June 15, 2020 Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering use of Thykamine™ for the treatment of Ulcerative Colitis

June 10, 2020 Devonian Health Group announces completion of Enrollment in its Phase 2 Clinical Trial of Thykamine™ for the Treatment of mild-to-moderate Atopic Dermatitis in adult population

June 05, 2020 Devonian Health Group Announces Change to its Board of Directors

June 04, 2020 Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs

May 21, 2020 Devonian Health Group Announces the nomination of Dr André P. Boulet to the American Botanical Drug Association

May 04, 2020 Devonian Health Group Announces the Closing of $1,805,000 Non-Brokered Financing

April 24, 2020 Devonian Health Group Announces an Increase to its Non-Brokered Financing to $2,000,000

April 22, 2020 Devonian Health Group Announces the Issuance of Securities in Interest Settlement Due to Debenture Holders, a $330,000 Non-Brokered Financing and the Grant of Options

February 11, 2020 Devonian Health Group Announces R-Spinasome® anti-aging technology global sales and marketing partnership

January 29, 2020 Devonian issues settlements of interest due to a debenture holder and announces the results of the annual general meeting of shareholders

January 23, 2020 Devonian Health Group Announces presentation to the World Conference on Ageing and Gerontology and a correction on expiry date of warrants

January 16, 2020 Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in its Montmagny Facility